List of Tables
Table 1. Global Purpura Therapy Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Purpura Therapy Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Purpura Therapy Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Purpura Therapy Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Purpura Therapy Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Purpura Therapy Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Purpura Therapy Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Purpura Therapy Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Purpura Therapy Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Purpura Therapy Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Purpura Therapy Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Purpura Therapy Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Purpura Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Purpura Therapy Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Purpura Therapy Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Purpura Therapy Drugs Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Purpura Therapy Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Purpura Therapy Drugs Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Purpura Therapy Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Purpura Therapy Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Purpura Therapy Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Purpura Therapy Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Purpura Therapy Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Purpura Therapy Drugs Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Purpura Therapy Drugs Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Purpura Therapy Drugs Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Purpura Therapy Drugs Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Purpura Therapy Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Purpura Therapy Drugs Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Purpura Therapy Drugs Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Purpura Therapy Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Purpura Therapy Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Purpura Therapy Drugs Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Purpura Therapy Drugs Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Purpura Therapy Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Purpura Therapy Drugs Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Purpura Therapy Drugs Sales (K Pcs) by Type (2020-2025)
Table 51. Global Purpura Therapy Drugs Sales (K Pcs) by Type (2026-2031)
Table 52. Global Purpura Therapy Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Purpura Therapy Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Purpura Therapy Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Purpura Therapy Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Purpura Therapy Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Purpura Therapy Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Purpura Therapy Drugs Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Purpura Therapy Drugs Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Purpura Therapy Drugs Sales (K Pcs) by Application (2020-2025)
Table 61. Global Purpura Therapy Drugs Sales (K Pcs) by Application (2026-2031)
Table 62. Global Purpura Therapy Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Purpura Therapy Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Purpura Therapy Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Purpura Therapy Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Purpura Therapy Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Purpura Therapy Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Purpura Therapy Drugs Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Purpura Therapy Drugs Price (USD/Pcs) by Application (2026-2031)
Table 70. Bristol-Myers Squibb Company Company Information
Table 71. Bristol-Myers Squibb Company Description and Business Overview
Table 72. Bristol-Myers Squibb Company Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Bristol-Myers Squibb Company Purpura Therapy Drugs Product
Table 74. Bristol-Myers Squibb Company Recent Developments/Updates
Table 75. Pfizer Inc Company Information
Table 76. Pfizer Inc Description and Business Overview
Table 77. Pfizer Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Pfizer Inc Purpura Therapy Drugs Product
Table 79. Pfizer Inc Recent Developments/Updates
Table 80. GlaxoSmithKline Plc Company Information
Table 81. GlaxoSmithKline Plc Description and Business Overview
Table 82. GlaxoSmithKline Plc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Plc Purpura Therapy Drugs Product
Table 84. GlaxoSmithKline Plc Recent Developments/Updates
Table 85. Novartis AG Company Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Novartis AG Purpura Therapy Drugs Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Hovione Company Information
Table 91. Hovione Description and Business Overview
Table 92. Hovione Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Hovione Purpura Therapy Drugs Product
Table 94. Hovione Recent Developments/Updates
Table 95. Sanofi Winthrop Industrie S.A. Company Information
Table 96. Sanofi Winthrop Industrie S.A. Description and Business Overview
Table 97. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product
Table 99. Sanofi Winthrop Industrie S.A. Recent Developments/Updates
Table 100. Hoffman-L Roche Company Information
Table 101. Hoffman-L Roche Description and Business Overview
Table 102. Hoffman-L Roche Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Hoffman-L Roche Purpura Therapy Drugs Product
Table 104. Hoffman-L Roche Recent Developments/Updates
Table 105. Amgen Inc Company Information
Table 106. Amgen Inc Description and Business Overview
Table 107. Amgen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Amgen Inc Purpura Therapy Drugs Product
Table 109. Amgen Inc Recent Developments/Updates
Table 110. Grifols Biologicals Inc Company Information
Table 111. Grifols Biologicals Inc Description and Business Overview
Table 112. Grifols Biologicals Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Grifols Biologicals Inc Purpura Therapy Drugs Product
Table 114. Grifols Biologicals Inc Recent Developments/Updates
Table 115. Ablynx NV Company Information
Table 116. Ablynx NV Description and Business Overview
Table 117. Ablynx NV Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Ablynx NV Purpura Therapy Drugs Product
Table 119. Ablynx NV Recent Developments/Updates
Table 120. Biogen Inc Company Information
Table 121. Biogen Inc Description and Business Overview
Table 122. Biogen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Biogen Inc Purpura Therapy Drugs Product
Table 124. Biogen Inc Recent Developments/Updates
Table 125. KM Biologics Company Information
Table 126. KM Biologics Description and Business Overview
Table 127. KM Biologics Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. KM Biologics Purpura Therapy Drugs Product
Table 129. KM Biologics Recent Developments/Updates
Table 130. Lee's Pharmaceutical Holdings Ltd Company Information
Table 131. Lee's Pharmaceutical Holdings Ltd Description and Business Overview
Table 132. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product
Table 134. Lee's Pharmaceutical Holdings Ltd Recent Developments/Updates
Table 135. Omeros Corp Company Information
Table 136. Omeros Corp Description and Business Overview
Table 137. Omeros Corp Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Omeros Corp Purpura Therapy Drugs Product
Table 139. Omeros Corp Recent Developments/Updates
Table 140. Takeda Company Information
Table 141. Takeda Description and Business Overview
Table 142. Takeda Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Takeda Purpura Therapy Drugs Product
Table 144. Takeda Recent Developments/Updates
Table 145. Roch Company Information
Table 146. Roch Description and Business Overview
Table 147. Roch Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Roch Purpura Therapy Drugs Product
Table 149. Roch Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Purpura Therapy Drugs Distributors List
Table 153. Purpura Therapy Drugs Customers List
Table 154. Purpura Therapy Drugs Market Trends
Table 155. Purpura Therapy Drugs Market Drivers
Table 156. Purpura Therapy Drugs Market Challenges
Table 157. Purpura Therapy Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Purpura Therapy Drugs
Figure 2. Global Purpura Therapy Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Purpura Therapy Drugs Market Share by Type: 2024 & 2031
Figure 4. Allergic Purpura Product Picture
Figure 5. Thrombocytopenic Purpura Product Picture
Figure 6. Global Purpura Therapy Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Purpura Therapy Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital Use
Figure 9. Clinic Use
Figure 10. Household
Figure 11. Others
Figure 12. Global Purpura Therapy Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Purpura Therapy Drugs Market Size (2020-2031) & (US$ Million)
Figure 14. Global Purpura Therapy Drugs Sales (2020-2031) & (K Pcs)
Figure 15. Global Purpura Therapy Drugs Average Price (USD/Pcs) & (2020-2031)
Figure 16. Purpura Therapy Drugs Report Years Considered
Figure 17. Purpura Therapy Drugs Sales Share by Manufacturers in 2024
Figure 18. Global Purpura Therapy Drugs Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Purpura Therapy Drugs Players: Market Share by Revenue in Purpura Therapy Drugs in 2024
Figure 20. Purpura Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Purpura Therapy Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
Figure 23. North America Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
Figure 27. Europe Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
Figure 28. Germany Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Purpura Therapy Drugs Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Purpura Therapy Drugs Revenue Market Share by Region (2020-2031)
Figure 35. China Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Purpura Therapy Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Purpura Therapy Drugs by Type (2020-2031)
Figure 57. Global Purpura Therapy Drugs Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Purpura Therapy Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Purpura Therapy Drugs by Application (2020-2031)
Figure 60. Global Purpura Therapy Drugs Price (USD/Pcs) by Application (2020-2031)
Figure 61. Purpura Therapy Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
